Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L12 pseudogene 35 (RPL12P35) is a processed pseudogene corresponding to the ribosomal protein L12 gene. Pseudogenes are non-functional segments of DNA that resemble functional genes but generally do not produce active proteins. RPL12P35 itself is not known to encode a functional protein or play a direct role in biological processes or disease. Its presence is mostly relevant in the context of genome annotation and evolutionary studies. Confusion can arise because the functional ribosomal protein L12 (encoded by RPL12) is a component of the ribosome involved in protein synthesis[3][5], whereas RPL12P35 is simply one of many pseudogene copies of that gene found scattered in the human genome[4][2][8]. The functional ribosomal protein L12 (RPL12) is an essential ribosomal protein found in the 60S subunit, involved in protein translation and associated with certain diseases[3][5]. The pseudogene RPL12P35 does not encode an active protein and is not a valid drug target, receptor, enzyme, transporter, etc. Pseudogenes like RPL12P35 are mainly catalogued for genomics purposes; their function, if any, is rarely well established[8]. No evidence supports RPL12P35 as a biomarker, drug target, therapeutic risk, or biological actor. If you sought the functional ribosomal protein, RPL12 (ribosomal protein L12), those entries would differ substantially.
Not applicable; pseudogenes do not generally have mechanisms of action relevant to drug targeting
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L12 pseudogene 35 (RPL12P35).